Wednesday, July 8, 2026

biotech · Presbyopia · Eye Diseases · LENZ

LENZ Therapeutics

LENZ Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

San Diego, USA HQ
176 Employees
Public company Type
LENZ · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Employees
176
Programs
5
Drugs
6
Patents
20
Intelligence · Clinical Trials

LENZ Therapeutics clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to LENZ Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

LENZ Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for LENZ Therapeutics.

  1. Aceclidine+tropicamide combination — Phase 2

    Clinical update
  2. Aceclidine + Brimonidine — Phase 1

    Clinical update
  3. LNZ101 (Aceclidine /Brimonidine) ophthalmic solution — Phase 1

    Clinical update
  4. Aceclidine+Brimonidine combination ophthalmic solution — Phase 3

    Clinical update
  5. PRX-100 — Phase 2

    Clinical update

Trial registry

10 studies